Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma

Immune-modulatory therapy, especially with immune-checkpoint inhibitors (ICIs), has reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can effectively delay the progression of aggressive tumors and inhibit tumor recurrence and metastasis in many different tumor types. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Tian-ming, Liu, Yao, Wang, Jia-bei, Liu, Lian-xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678689/
https://www.ncbi.nlm.nih.gov/pubmed/33235462
http://dx.doi.org/10.2147/OTT.S279858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678689/
https://www.ncbi.nlm.nih.gov/pubmed/33235462
http://dx.doi.org/10.2147/OTT.S279858

Ejemplares similares